Grant has over a decade of strategy, finance, and commercial operations experience in the biopharma and medical device industry. Prior to joining our team in 2015, Grant led marketing operations for Amedra Pharmaceuticals and Lineage Therapeutics, which was successfully sold to Impax Laboratories in 2015. Before entering the biopharmaceutical industry Grant held numerous commercial roles in the Medical Device sector; most notably as the head of US operations and global marketing for an Israel-based organization, where they successfully commercialized a novel orthopedic device in over 30 countries. He holds his BS in International Business from Johnson & Wales University.